Immunomodulatory antitumor effect of interferon‑beta combined with gemcitabine in pancreatic cancer-Reference-Cited by-同舟云学术

Immunomodulatory antitumor effect of interferon‑beta combined with gemcitabine in pancreatic cancer

Published:2022-07-01 Issue:2 Volume:61 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Blaauboer Amber¹,Van Koetsveld Peter²,Mustafa Dana³,Dumas Jasper³,Dogan Fadime²,Van Zwienen Suzanne²,Van Eijck Casper¹,Hofland Leo²

Affiliation:

1. Department of Surgery, the Tumor Immuno‑Pathology Laboratory, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands

2. Department of Internal Medicine, Division of Endocrinology, the Tumor Immuno‑Pathology Laboratory, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands

3. Department of Pathology, the Tumor Immuno‑Pathology Laboratory, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference50 articles.

1. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

2. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data;Bengtsson;Sci Rep,2020

3. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N Engl J Med,2018

4. Pancreatic cancer chemoresistance to gemcitabine;Amrutkar;Cancers (Basel),2017

5. Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: A single-institution phase II study;Linehan;Ann Surg,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms;Cancers;2023-08-29

2. Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment;Cancers;2023-03-23